Research Studies
Back to Results
Individual Patient Program for Patients with BRAF V600E/K mutation-positive Metastatic Melanoma and Other Indications with Clinical Evidence of Potential Treatment Efficacy Treatment with Trametinib and Bevacizumab
Details
Age
Child
Type of Study
Treatment
Location
Childrens Hospital Colorado
Principal Investigator
Nathan Dahl, DO
Study ID
Protocol Number: 19-2412
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers